FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk
Endpoints News 24 nov. 2025 Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
BioWorld 24 nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioPharma Dive 24 nov. 2025 Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer